| Biologic Therapy |
0 |
0.88 |
| Cancer |
0 |
0.79 |
| Skin Cancer |
0 |
0.76 |
| Antineoplastic Drug |
0 |
0.62 |
| Michigan |
0 |
0.52 |
| Prescription Drugs |
0 |
0.26 |
| Food and Drug Administration (FDA) |
0 |
0.17 |
| Hodgkin Lymphoma |
0 |
0.13 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.13 |
| Cutaneous T-Cell Lymphoma |
0 |
0.11 |
| Humanized Monoclonal Antibody |
0 |
0.11 |
| Neuroendocrine Tumor |
0 |
0.08 |
| Antibody Drug Conjugates |
0 |
0.07 |
| Hand |
0 |
0.07 |
| Hematology |
0 |
0.07 |
| Lymphoma |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |